Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTissue Regenix Group Regulatory News (TRX)

  • This share is currently suspended. It was suspended at a price of 7.23
  • There is currently no data for TRX

Acquisition

17 Aug 2005 11:13

Torex Retail PLC17 August 2005 17 August 2005 EXPANSION OF IRISH OPERATIONS Torex Retail Plc ("Torex"), the leading international retail systems business,is pleased to announce that it has acquired the Retail Petroleum Systems groupof companies ("RPS" or "the Company") for a maximum consideration of €9 million. RPS is based in Dublin and is the leading supplier of forecourt equipment andcomputer systems to the Irish petroleum retail market. The company provides highquality turnkey solutions and ongoing maintenance to all sectors of the marketfrom major oil companies to local independently owned stations. For the year ended 31 January 2005 RPS achieved revenues of €12.3 million with apre-tax profit of €262,000. RPS had net assets of €788,000 at 31 January 2005and employs some 78 staff. The consideration comprises an initial payment of €6.0 million to be satisfiedby the payment of €5.0 million in cash and €1.0 million by the issue of 593,570new Torex shares. Deferred consideration of €3 million is payable dependant oncertain performance criteria. Application will be made for the new shares to beissued pursuant to the consideration for the acquisition to be admitted totrading on AIM. Admission is expected to become effective on 23 August 2005. Chris Moore, Chief Executive of Torex Retail Plc, commented: "The acquisition of RPS significantly expands our petroleum retailing operationsin Ireland and increases the potential for sale of our own IPR products intothis market. RPS has a very strong management team and the increased criticalmass and field engineering infrastructure following the integration of RPS willgive rise to enhanced customer service whilst at the same time creatingeconomies of scale." Enquiries: Torex Retail plc 0870 050 9900Chris Moore, Chief ExecutiveRichard Thompson, Finance Director Citigate Dewe Rogerson 020 7638 9571Ginny Pulbrook / Seb Hoyle Notes to Editors: About Torex Retail plc Torex Retail is a leading independent provider of cutting edge retail technologysolutions to many of the world's principal retailers. Since the company'sflotation in spring 2004 Torex Retail has achieved rapid growth across all ofits markets and has rigorously pursued its goal of becoming the provider ofchoice. As a result, the company now has a presence in all of the major marketsaround the world and has built a strong platform for future growth in line withits strategy. Torex's Retail's product and solution set spans high street andout-of-town retail as well as the petroleum and convenience sector and with over6,000 customer relationships, including Tesco, Woolworth, Selfridges, Shell andArgos, the company has earned a leading reputation amongst retailers. TorexRetail has more than 2500 st Saff based in 17 countries. www.torexretail.com This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
6th Mar 20157:09 amRNSDermaPure gains Medicare coverage approval
5th Mar 20151:36 pmRNSIssue of equity and total voting rights
5th Mar 20151:18 pmRNSIssue of equity and total voting rights
5th Mar 201510:38 amRNSUK Patient has world's first OrthoPure XM implant
26th Feb 201510:43 amRNSResignation of Dr Alison Fielding
9th Feb 201512:05 pmRNSResult of General Meeting
4th Feb 201510:59 amRNSIssue of equity and total voting rights
22nd Jan 201511:13 amRNSResults of Placing
22nd Jan 20157:00 amRNSProposed placing of new Ordinary Shares
1st Dec 20149:45 amRNSHolding(s) in Company
28th Nov 20149:45 amRNSHolding(s) in Company
25th Nov 20148:15 amRNSNotice of allowance for US meniscus patent
5th Nov 20147:00 amRNSTissue Regenix gains Medicare and Medicaid Q code
29th Oct 20147:00 amRNSInterim Results
22nd Oct 20149:01 amRNSInterim Results and Capital Markets Day
20th Oct 201410:19 amRNSdCELL(R) presented at prestigious EACTS congress
17th Oct 20143:35 pmRNSInitial Clinical Trial Results
10th Sep 20149:00 amRNSdCELL® technology presented at Royal Society event
30th Jul 20147:00 amRNSUK meniscus clinical trial & DermaPure US updates
25th Jul 20147:00 amRNSTissue Regenix adds European bladder matrix patent
18th Jul 201411:11 amRNSIssue of equity and total voting rights
27th Jun 20143:06 pmRNSResult of AGM
12th Jun 20147:00 amRNSTissue Regenix announces launch of DermaPure in US
22nd May 20147:00 amRNSPreliminary Decision to Approve "Q" Code Request
20th May 20147:00 amRNSDeferred Annual Bonus Award
19th May 201410:21 amRNSAnnual Report & Accounts and Notice of AGM
19th May 20147:00 amRNSPreliminary results for year ended 31 January 2014
16th May 20141:00 pmRNSTissue Regenix adds US patent
12th May 201411:00 amRNSNotice of Preliminary Results
30th Apr 20145:14 pmRNSHolding(s) in Company
28th Apr 20147:00 amRNSTissue Regenix adds Chinese patent
24th Apr 20148:40 amRNSHolding(s) in Company
4th Feb 20143:03 pmRNSIssue of Share Options
31st Jan 20141:11 pmRNSHolding(s) in Company
14th Jan 20145:22 pmRNSIssue of equity and total voting rights
9th Jan 201411:11 amRNSIssue of equity and total voting rights
19th Dec 20137:00 amRNSTissue Regenix to attend JPMorgan Healthcare Event
12th Dec 20137:00 amRNSTissue Regenix signs US distribution agreements
22nd Nov 20137:00 amRNSDirector Share Purchase
29th Oct 20137:00 amRNSPresentation at Proactiveinvestors Forum in Dublin
28th Oct 20134:49 pmRNSDirector Share Purchase
21st Oct 20137:00 amRNSPublication of DermaPure UK trial results
17th Oct 20134:41 pmRNSHolding(s) in Company
17th Oct 20134:41 pmRNSHolding(s) in Company
17th Oct 20134:41 pmRNSHolding(s) in Company
14th Oct 20137:00 amRNSTissue Regenix USA successful technology transfer
8th Oct 20137:00 amRNSInterim Results for six months ended 31 July 2013
12th Aug 20137:00 amRNSTissue Regenix USA Appoints VP of Marketing
6th Aug 20139:41 amRNSHolding(s) in Company
5th Aug 20137:00 amRNSTissue Regenix USA Appoints VP of Operations

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.